BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27602772)

  • 1. c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma.
    Ciribilli Y; Singh P; Inga A; Borlak J
    Oncotarget; 2016 Oct; 7(40):65514-65539. PubMed ID: 27602772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas.
    Ciribilli Y; Singh P; Spanel R; Inga A; Borlak J
    Oncotarget; 2015 Oct; 6(31):31569-92. PubMed ID: 26427040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NPM3 as an Unfavorable Prognostic Biomarker Involved in Oncogenic Pathways of Lung Adenocarcinoma
    Chen L; Yang D; Huang F; Xu W; Luo X; Mei L; He Y
    Comb Chem High Throughput Screen; 2024; 27(2):203-213. PubMed ID: 37114782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription profiling of lung adenocarcinomas of c-myc-transgenic mice: identification of the c-myc regulatory gene network.
    Reymann S; Borlak J
    BMC Syst Biol; 2008 May; 2():46. PubMed ID: 18498649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 2-DE MALDI-TOF study to identify disease regulated serum proteins in lung cancer of c-myc transgenic mice.
    Chatterji B; Borlak J
    Proteomics; 2009 Feb; 9(4):1044-56. PubMed ID: 19180532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer.
    Hunecke D; Spanel R; Länger F; Nam SW; Borlak J
    J Pathol; 2012 Dec; 228(4):520-33. PubMed ID: 22653869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of glycosylphosphatidylinositol-anchored proteins and GPI-phospholipase D in a c-Myc transgenic mouse model of hepatocellular carcinoma and human HCC.
    Ritorto MS; Rhode H; Vogel A; Borlak J
    Biol Chem; 2016 Nov; 397(11):1147-1162. PubMed ID: 27232633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells.
    Doose G; Haake A; Bernhart SH; López C; Duggimpudi S; Wojciech F; Bergmann AK; Borkhardt A; Burkhardt B; Claviez A; Dimitrova L; Haas S; Hoell JI; Hummel M; Karsch D; Klapper W; Kleo K; Kretzmer H; Kreuz M; Küppers R; Lawerenz C; Lenze D; Loeffler M; Mantovani-Löffler L; Möller P; Ott G; Richter J; Rohde M; Rosenstiel P; Rosenwald A; Schilhabel M; Schneider M; Scholz I; Stilgenbauer S; Stunnenberg HG; Szczepanowski M; Trümper L; Weniger MA; ; Hoffmann S; Siebert R; Iaccarino I
    Proc Natl Acad Sci U S A; 2015 Sep; 112(38):E5261-70. PubMed ID: 26351698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma.
    Ciribilli Y; Borlak J
    Oncotarget; 2017 Nov; 8(60):101808-101831. PubMed ID: 29254206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma.
    Seitz V; Butzhammer P; Hirsch B; Hecht J; Gütgemann I; Ehlers A; Lenze D; Oker E; Sommerfeld A; von der Wall E; König C; Zinser C; Spang R; Hummel M
    PLoS One; 2011; 6(11):e26837. PubMed ID: 22102868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
    Ritorto MS; Borlak J
    J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomal protein S14 negatively regulates c-Myc activity.
    Zhou X; Hao Q; Liao JM; Liao P; Lu H
    J Biol Chem; 2013 Jul; 288(30):21793-801. PubMed ID: 23775087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-binding motif protein 10 inactivates c-Myc by partnering with ribosomal proteins uL18 and uL5.
    Lee H; Jung JH; Ko HM; Park H; Segall AM; Sheffmaker RL; Wang J; Frey WD; Pham N; Wang Y; Zhang Y; Jackson JG; Zeng SX; Lu H
    Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2308292120. PubMed ID: 38032932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth.
    Gouw AM; Margulis K; Liu NS; Raman SJ; Mancuso A; Toal GG; Tong L; Mosley A; Hsieh AL; Sullivan DK; Stine ZE; Altman BJ; Schulze A; Dang CV; Zare RN; Felsher DW
    Cell Metab; 2019 Sep; 30(3):556-572.e5. PubMed ID: 31447321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. snoRNAs are a novel class of biologically relevant Myc targets.
    Herter EK; Stauch M; Gallant M; Wolf E; Raabe T; Gallant P
    BMC Biol; 2015 Apr; 13():25. PubMed ID: 25888729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.
    Aravalli RN; Talbot NC; Steer CJ
    World J Gastroenterol; 2015 Feb; 21(7):2011-29. PubMed ID: 25717234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion.
    Chalishazar MD; Wait SJ; Huang F; Ireland AS; Mukhopadhyay A; Lee Y; Schuman SS; Guthrie MR; Berrett KC; Vahrenkamp JM; Hu Z; Kudla M; Modzelewska K; Wang G; Ingolia NT; Gertz J; Lum DH; Cosulich SC; Bomalaski JS; DeBerardinis RJ; Oliver TG
    Clin Cancer Res; 2019 Aug; 25(16):5107-5121. PubMed ID: 31164374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc directly targets an over-expression of pyruvate carboxylase in highly invasive breast cancer.
    Lao-On U; Rojvirat P; Chansongkrow P; Phannasil P; Siritutsoontorn S; Charoensawan V; Jitrapakdee S
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165656. PubMed ID: 31874204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The c-Myc targeting hnRNPAB promotes lung adenocarcinoma cell proliferation via stabilization of CDK4 mRNA.
    Xu C; Li B; Yu N; Yao B; Wang F; Mei Y
    Int J Biochem Cell Biol; 2023 Mar; 156():106372. PubMed ID: 36657708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Omics Analysis Identifies MGA as a Negative Regulator of the MYC Pathway in Lung Adenocarcinoma.
    Llabata P; Mitsuishi Y; Choi PS; Cai D; Francis JM; Torres-Diz M; Udeshi ND; Golomb L; Wu Z; Zhou J; Svinkina T; Aguilera-Jimenez E; Liu Y; Carr SA; Sanchez-Cespedes M; Meyerson M; Zhang X
    Mol Cancer Res; 2020 Apr; 18(4):574-584. PubMed ID: 31862696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.